The US Food and Drugs Administration (FDA) now requires that all bisphosphonate drugs (used to treat osteoporosis) now carry a warning label detailing a potential side effect of the drug that could increase the risk of a rare type of fracture. Regulators in the UK are also looking into these reports.

Full article